H5N1 Milk Detection Study
ConditionInfluenza
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-64
SponsorEmory University
About this trial
The purpose of this study is to determine whether drinking pasteurized milk (milk heated to kill harmful germs) that contains inactive particles of a flu virus called A(H5) could lead to the detection of the virus in the nose or throat. Inactive particles are not capable of causing disease. The results will help the Centers for Disease Control and Prevention (CDC) better understand how milk consumption could affect flu surveillance. Investigators also want to see if the body produces antibodies in response to this milk consumption.
Eligibility criteria
Qualifiers
Individuals aged 18-64 years
BMI ≤ 35 kg/m2
Able to understand and give informed consent (American English) and comply with study visits and procedures.
In good general health based on medical history and the investigator's clinical judgment.
Disqualifiers
Symptoms of acute respiratory illness or conjunctivitis within 7 days
Febrile illness in the previous 72 hours
Recent influenza antiviral use (within 14 days)
Immunosuppression due to illness or medications
Trial design
Treatments tested in this trial
- Pasteurized milk contaminated with killed A(H5) virus
Treatment groups
30 Participants
are divided into 2 treatment groupsSponsors and collaborators
Emory University
Lead sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Collaborator
Source ClinicalTrials.gov